ingredientIbrutinib (140mg)
substitutesIbrucent 140mg 90s
treatmentMantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia)
Medicine Overview by Anukar Pharmacy
( Imbruvica 140mg 120 Capsule )
TreatmentImbruvica 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (Chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy or with 17p deletion.
Side EffectsHeadache, Joint pain, Fever, Diarrhoea, Vomiting, Stomatitis (Inflammation of the mouth), Nausea, Constipation, Low blood platelets, Decreased white blood cell count (neutrophils), Upper respiratory tract infection.
Method of UseTake this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.
How WorksImbruvica 140mg Capsule is a Bruton??s tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Warning by Anukar Pharmacy
( Imbruvica 140mg 120 Capsule )
Special precautions for ( Imbruvica 140mg 120 Capsule ) Heads up
| aspect | highlight | details |
|---|---|---|
Alcohol
|
There is no data available. Please consult doctor before consuming the drug. | |
Pregnancy
|
There is no data available. Please consult doctor before consuming the drug. | |
Lactation
|
There is no data available. Please consult doctor before consuming the drug. | |
Driving
|
There is no data available. Please consult doctor before consuming the drug. | |
Kidney
|
There is no data available. Please consult doctor before consuming the drug. | |
Liver
|
There is no data available. Please consult doctor before consuming the drug. |
Disclaimer
The information of Anukar Pharmacy is for reference purpose only, and Anukar Pharmacy or Anukar Pharmacy or Anukar Pharmacy is not intended to be a replacement of professional medical advice, diagnosis, or treatment. Anukar Pharmacy suggest to ask the advice of a physician or any qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of anything you have learned from Anukar Pharmacy.
| 药名 | 依鲁替尼 |
| 厂家 | JANSSEN |
| 成分 | 依鲁替尼 |
| 说明 |
依鲁,替尼,IMBRUVICA,
依鲁替尼是一种口服的布鲁顿酪氨酸激酶（BTK）抑制剂，通过抑制肿瘤细胞复制和转移需要的BTK而起到抗癌作用。2013年11月被批准用于治疗复发性套细胞淋巴癌。2014年2月被批准用于治
治疗作用：(1)淋巴瘤(MCL)曾接受至少一种既往治疗。根据总反应率授权加速批准为这个适应证。继续批准这个适应证可能取决于在验证性试验中证实临床获益。 (2)慢性淋巴细胞白血病(CLL)曾接受至少一种既往治疗。 (3)慢性淋巴细胞白血病有17p缺失。
|
* 以上中文信息由印度阿努卡药房收集的Imbruvica 140mg 120 Capsule, Janssen（依鲁替尼）中文网络信息和软件翻译获得，阿努卡药房认为Imbruvica 140mg 120 Capsule, Janssen（依鲁替尼）中文产品介绍信息存在与Imbruvica 140mg 120 Capsule, Janssen（依鲁替尼）实际数据不一致的可能。阿努卡药房请用户把Imbruvica 140mg 120 Capsule, Janssen（依鲁替尼）页面数据作为参考。印度阿努卡药房建议用户在实际使用Imbruvica 140mg 120 Capsule, Janssen（依鲁替尼）数据或者信息时，以Imbruvica 140mg 120 Capsule, Janssen（依鲁替尼）制造商公开发布的Imbruvica 140mg 120 Capsule, Janssen（依鲁替尼）商品信息为参考。使用方法，以用户医生建议使用Imbruvica 140mg 120 Capsule, Janssen（依鲁替尼）决定为参考。用户任何关于Imbruvica 140mg 120 Capsule, Janssen（依鲁替尼）的建议，可以通知印度阿努卡药房，或通知阿努卡在线客服人员。谢谢
